Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.3915
-0.0235 (-5.66%)
At close: Oct 29, 2026
RVPH Market Cap
RVPH has a market cap or net worth of $5.13 million as of October 30, 2026. It is the 44,723rd most valuable company in the world and the 5,961st biggest in the United States. Its market cap has decreased by 92.21% in one year.
Market Cap
5.13M
Enterprise Value
-14.61M
Revenue
n/a
Global Rank
Country Rank
#5,961 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 18, 2018, RVPH's market cap has decreased from 25.21M to 5.13M, a decrease of -79.64%. That is a compound annual growth rate of -17.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 5.13M | -84.26% |
| Dec 31, 2025 | 32.60M | -61.33% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adaptimmune Therapeutics | 6.92M |
| VitaSpring Biomedical | 6.58M |
| TRON Group | 6.11M |
| Curative Biotechnology | 5.93M |
| Eastgate Biotech | 5.29M |
| LianMedical | 4.80M |
| OSR Health | 4.59M |
| Institute of Biomedical Research | 4.40M |